Search for Clinical Trial Results
Anaplastic Oligodendroglioma - 21 Studies Found
Status | Study |
Completed |
Study Name: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma Condition:
Date: 2006-08-08 Interventions: Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
Completed |
Study Name: Temozolomide in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions: Drug: temozolomide |
Active, not recruiting |
Study Name: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Condition:
Date: 2006-11-16 Interventions: Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
Completed |
Study Name: Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Active, not recruiting |
Study Name: Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Condition:
Date: 2007-12-22 Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa Temozolomide 200mg/m2 PO Days 1-5 recycle |
No longer available |
Study Name: Expanded Access to ANG1005 for Individual Patients Condition:
Interventions: Drug: ANG1005 |
Recruiting |
Study Name: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Condition:
Interventions: |
Completed |
Study Name: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Topotecan in Treating Patients With Recurrent Brain Tumors Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions: Drug: topotecan hydrochloride |